|
US5346703A
|
|
Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels
|
|
US5298260A
|
|
Topical drug delivery with polyoxyalkylene polymer thermoreversible gels adjustable for pH and osmolality
|
|
US5306501A
|
|
Drug delivery by injection with thermoreversible gels containing polyoxyalkylene copolymers
|
|
US5292516A
|
|
Body cavity drug delivery with thermoreversible gels containing polyoxyalkylene copolymers
|
|
US5318780A
|
|
Medical uses of in situ formed gels
|
|
US5300295A
|
|
Ophthalmic drug delivery with thermoreversible polyoxyalkylene gels adjustable for pH
|
|
CA2044878A1
|
|
Thermally reversible and irreversible gels
|
|
GR910100193A
|
|
Preparation of pharmaceutical and other matrix systems by solid-state dissolution
|
|
DK70391D0
|
|
Preparation of pharmaceutical and other matrix systems and their application
|
|
WO9109591A1
|
|
Preparation of pharmaceutical and other matrix systems by solid-state dissolution
|
|
SG49249A1
|
|
Preparation of pharmaceutical and other matrix systems by solid state dissolution
|
|
US5376693A
|
|
Thermo-irreversible gel corneal contact lens formed in situ
|
|
US5126141A
|
|
Composition and method for post-surgical adhesion reduction with thermo-irreversible gels of polyoxyalkylene polymers and ionic polysaccharides
|
|
US5071644A
|
|
Topical drug delivery with thermo-irreversible gels
|
|
US5077033A
|
|
Ophthalmic drug delivery with thermo-irreversible gels of polxoxyalkylene polymer and ionic polysaccharide
|
|
US5143731A
|
|
Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels
|
|
US5124151A
|
|
Drug delivery by injection with thermo-irreversible gels
|
|
US5135751A
|
|
Composition for reducing postsurgical adhesions
|
|
US4911926A
|
|
Method and composition for reducing postsurgical adhesions
|
